Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study - The Lancet Public Health
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial - The Lancet Global Health
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes - The Lancet Infectious Diseases
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review - The Lancet Oncology
Linking interdisciplinary and multiscale approaches to improve healthspan—a new UK model for collaborative research networks in ageing biology and clinical translation - The Lancet Healthy Longevity
Graphical abstracts
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study - The Lancet Haematology
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas
A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study - The Lancet
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis - The Lancet Oncology
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study - The Lancet Infectious Diseases
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet
Migraine: integrated approaches to clinical management and emerging treatments - The Lancet
The Lancet Handbook of Essential Concepts in Clinical Research (The Lancet Handbooks): Schulz PhD MBA, Kenneth, Grimes MD, David A.: 9780080448664: Amazon.com: Books
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context - The Lancet Respiratory Medicine
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy - The Lancet Infectious Diseases
Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials - The Lancet Regional Health –
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial - The Lancet
Stroke–heart syndrome: clinical presentation and underlying mechanisms - The Lancet Neurology
An overview of clinical research: the lay of the land - The Lancet
